Daniel A. Pollyea, MD, MS (IMAGE)
Caption
Daniel A. Pollyea, MD, MS, reports at ASCO 2017 that despite NCCN guidelines, only 9 percent of AML patients receive all seven suggested genetic tests.
Credit
University of Colorado Cancer Center
Usage Restrictions
With attribution
License
Licensed content